ID   SYLC_HUMAN              Reviewed;        1176 AA.
AC   Q9P2J5; A2RRR4; A7E266; B4DJ10; Q2TU79; Q9NSE1;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2004, sequence version 2.
DT   10-MAY-2017, entry version 149.
DE   RecName: Full=Leucine--tRNA ligase, cytoplasmic;
DE            EC=6.1.1.4;
DE   AltName: Full=Leucyl-tRNA synthetase;
DE            Short=LeuRS;
GN   Name=LARS; Synonyms=KIAA1352;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT LYS-1088.
RC   TISSUE=Brain;
RA   Motegi H., Noda T., Shiba K.;
RT   "Cloning and sequence determination of a human cytoplasmic leucyl-tRNA
RT   synthetase gene.";
RL   Submitted (MAR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI.
RT   The complete sequences of 150 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Kim J.W., Kim H.K., Shin S.M.;
RT   "Identification of a human cell proliferation gene.";
RL   Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-167 AND SER-720, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (3.25 ANGSTROMS) OF 260-509 IN COMPLEX WITH
RP   (6-(ETHYLAMINO)-5-FLUOROBENZO[C][1,2]OXABOROL-1(3H)-OL) AND AMP, AND
RP   FUNCTION.
RX   PubMed=19426743; DOI=10.1016/j.jmb.2009.04.073;
RA   Seiradake E., Mao W., Hernandez V., Baker S.J., Plattner J.J.,
RA   Alley M.R.K., Cusack S.;
RT   "Crystal structures of the human and fungal cytosolic Leucyl-tRNA
RT   synthetase editing domains: A structural basis for the rational design
RT   of antifungal benzoxaboroles.";
RL   J. Mol. Biol. 390:196-207(2009).
RN   [13]
RP   VARIANT ILFS1 CYS-373, AND VARIANT ARG-82.
RX   PubMed=22607940; DOI=10.1016/j.ymgme.2012.04.017;
RA   Casey J.P., McGettigan P., Lynam-Lennon N., McDermott M., Regan R.,
RA   Conroy J., Bourke B., O'Sullivan J., Crushell E., Lynch S., Ennis S.;
RT   "Identification of a mutation in LARS as a novel cause of infantile
RT   hepatopathy.";
RL   Mol. Genet. Metab. 106:351-358(2012).
CC   -!- FUNCTION: Catalyzes the specific attachment of an amino acid to
CC       its cognate tRNA in a two step reaction: the amino acid (AA) is
CC       first activated by ATP to form AA-AMP and then transferred to the
CC       acceptor end of the tRNA. Exhibits a post-transfer editing
CC       activity to hydrolyze mischarged tRNAs.
CC       {ECO:0000269|PubMed:19426743}.
CC   -!- CATALYTIC ACTIVITY: ATP + L-leucine + tRNA(Leu) = AMP +
CC       diphosphate + L-leucyl-tRNA(Leu).
CC   -!- ENZYME REGULATION: (5-fluoro-1,3-dihydro-1-hydroxy-1,2-
CC       benzoxaborole) inhibits LARS by forming a covalent adduct with the
CC       3' adenosine of tRNA(Leu) at the editing site, thus locking the
CC       enzyme in an inactive conformation.
CC   -!- INTERACTION:
CC       P54136:RARS; NbExp=3; IntAct=EBI-356077, EBI-355482;
CC       Q8N122:RPTOR; NbExp=3; IntAct=EBI-356077, EBI-1567928;
CC       Q9NQL2:RRAGD; NbExp=13; IntAct=EBI-356077, EBI-992949;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9P2J5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9P2J5-2; Sequence=VSP_057205;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9P2J5-3; Sequence=VSP_057204;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Infantile liver failure syndrome 1 (ILFS1) [MIM:615438]:
CC       A life-threatening disorder of hepatic function that manifests
CC       with acute liver failure in the first few months of life. Clinical
CC       features include anemia, renal tubulopathy, developmental delay,
CC       seizures, failure to thrive, and liver steatosis and fibrosis.
CC       {ECO:0000269|PubMed:22607940}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA92590.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D84223; BAA95667.1; -; mRNA.
DR   EMBL; AB037773; BAA92590.1; ALT_INIT; mRNA.
DR   EMBL; AY513284; AAT08037.1; -; mRNA.
DR   EMBL; AY926480; AAX10025.1; -; mRNA.
DR   EMBL; AK295874; BAG58672.1; -; mRNA.
DR   EMBL; AC091887; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091959; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471062; EAW61848.1; -; Genomic_DNA.
DR   EMBL; BC131798; AAI31799.1; -; mRNA.
DR   EMBL; BC150213; AAI50214.1; -; mRNA.
DR   EMBL; BC151214; AAI51215.1; -; mRNA.
DR   EMBL; BC152422; AAI52423.1; -; mRNA.
DR   CCDS; CCDS34265.1; -. [Q9P2J5-1]
DR   CCDS; CCDS83029.1; -. [Q9P2J5-2]
DR   RefSeq; NP_001304893.1; NM_001317964.1.
DR   RefSeq; NP_001304894.1; NM_001317965.1. [Q9P2J5-2]
DR   RefSeq; NP_057544.2; NM_016460.3.
DR   RefSeq; NP_064502.9; NM_020117.10. [Q9P2J5-1]
DR   RefSeq; XP_011535958.1; XM_011537656.2. [Q9P2J5-2]
DR   UniGene; Hs.432674; -.
DR   PDB; 2WFD; X-ray; 3.25 A; A/B=260-509.
DR   PDBsum; 2WFD; -.
DR   ProteinModelPortal; Q9P2J5; -.
DR   SMR; Q9P2J5; -.
DR   BioGrid; 119584; 71.
DR   IntAct; Q9P2J5; 25.
DR   MINT; MINT-1158952; -.
DR   STRING; 9606.ENSP00000377954; -.
DR   BindingDB; Q9P2J5; -.
DR   ChEMBL; CHEMBL3258; -.
DR   DrugBank; DB00149; L-Leucine.
DR   MoonProt; Q9P2J5; -.
DR   iPTMnet; Q9P2J5; -.
DR   PhosphoSitePlus; Q9P2J5; -.
DR   SwissPalm; Q9P2J5; -.
DR   BioMuta; LARS; -.
DR   DMDM; 48428689; -.
DR   EPD; Q9P2J5; -.
DR   MaxQB; Q9P2J5; -.
DR   PaxDb; Q9P2J5; -.
DR   PeptideAtlas; Q9P2J5; -.
DR   PRIDE; Q9P2J5; -.
DR   Ensembl; ENST00000274562; ENSP00000274562; ENSG00000133706. [Q9P2J5-3]
DR   Ensembl; ENST00000394434; ENSP00000377954; ENSG00000133706. [Q9P2J5-1]
DR   Ensembl; ENST00000510191; ENSP00000426005; ENSG00000133706. [Q9P2J5-2]
DR   GeneID; 51520; -.
DR   KEGG; hsa:51520; -.
DR   UCSC; uc003lnx.2; human. [Q9P2J5-1]
DR   CTD; 51520; -.
DR   DisGeNET; 51520; -.
DR   GeneCards; LARS; -.
DR   HGNC; HGNC:6512; LARS.
DR   HPA; HPA036424; -.
DR   HPA; HPA040881; -.
DR   MalaCards; LARS; -.
DR   MIM; 151350; gene.
DR   MIM; 615438; phenotype.
DR   neXtProt; NX_Q9P2J5; -.
DR   OpenTargets; ENSG00000133706; -.
DR   Orphanet; 370088; Acute infantile liver failure-multisystemic involvement syndrome.
DR   PharmGKB; PA30297; -.
DR   eggNOG; KOG0437; Eukaryota.
DR   eggNOG; COG0495; LUCA.
DR   GeneTree; ENSGT00390000012163; -.
DR   HOGENOM; HOG000216621; -.
DR   HOVERGEN; HBG055325; -.
DR   InParanoid; Q9P2J5; -.
DR   KO; K01869; -.
DR   OMA; FYITTCA; -.
DR   OrthoDB; EOG091G01VH; -.
DR   PhylomeDB; Q9P2J5; -.
DR   TreeFam; TF105718; -.
DR   BRENDA; 6.1.1.4; 2681.
DR   Reactome; R-HSA-2408517; SeMet incorporation into proteins.
DR   Reactome; R-HSA-379716; Cytosolic tRNA aminoacylation.
DR   ChiTaRS; LARS; human.
DR   EvolutionaryTrace; Q9P2J5; -.
DR   GeneWiki; Leucyl-tRNA_synthetase; -.
DR   GenomeRNAi; 51520; -.
DR   PRO; PR:Q9P2J5; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000133706; -.
DR   CleanEx; HS_LARS; -.
DR   ExpressionAtlas; Q9P2J5; baseline and differential.
DR   Genevisible; Q9P2J5; HS.
DR   GO; GO:0017101; C:aminoacyl-tRNA synthetase multienzyme complex; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:CAFA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0012505; C:endomembrane system; IDA:CAFA.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:CAFA.
DR   GO; GO:0005764; C:lysosome; IMP:CAFA.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005096; F:GTPase activator activity; IMP:CAFA.
DR   GO; GO:0004823; F:leucine-tRNA ligase activity; IBA:GO_Central.
DR   GO; GO:0004832; F:valine-tRNA ligase activity; IBA:GO_Central.
DR   GO; GO:0034198; P:cellular response to amino acid starvation; IMP:CAFA.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IMP:CAFA.
DR   GO; GO:0071233; P:cellular response to leucine; IMP:CAFA.
DR   GO; GO:1990253; P:cellular response to leucine starvation; IMP:CAFA.
DR   GO; GO:0006429; P:leucyl-tRNA aminoacylation; IBA:GO_Central.
DR   GO; GO:0010507; P:negative regulation of autophagy; IMP:CAFA.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IMP:CAFA.
DR   GO; GO:1904263; P:positive regulation of TORC1 signaling; IMP:CAFA.
DR   GO; GO:0006622; P:protein targeting to lysosome; IMP:CAFA.
DR   GO; GO:0008361; P:regulation of cell size; IMP:CAFA.
DR   GO; GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome.
DR   GO; GO:0006438; P:valyl-tRNA aminoacylation; IBA:GO_Central.
DR   Gene3D; 1.10.730.10; -; 1.
DR   Gene3D; 3.40.50.620; -; 2.
DR   InterPro; IPR001412; aa-tRNA-synth_I_CS.
DR   InterPro; IPR002300; aa-tRNA-synth_Ia.
DR   InterPro; IPR004493; Leu-tRNA-synth_Ia_arc/euk.
DR   InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR   InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit.
DR   PANTHER; PTHR11946:SF99; PTHR11946:SF99; 1.
DR   Pfam; PF08264; Anticodon_1; 1.
DR   Pfam; PF00133; tRNA-synt_1; 2.
DR   SUPFAM; SSF47323; SSF47323; 1.
DR   SUPFAM; SSF50677; SSF50677; 2.
DR   TIGRFAMs; TIGR00395; leuS_arch; 1.
DR   PROSITE; PS00178; AA_TRNA_LIGASE_I; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Aminoacyl-tRNA synthetase; ATP-binding; Complete proteome; Cytoplasm;
KW   Disease mutation; Ligase; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Protein biosynthesis; Reference proteome.
FT   CHAIN         1   1176       Leucine--tRNA ligase, cytoplasmic.
FT                                /FTId=PRO_0000152150.
FT   REGION      260    509       Editing domain.
FT   MOTIF        53     63       "HIGH" region.
FT   MOTIF       716    720       "KMSKS" region.
FT   BINDING     719    719       ATP. {ECO:0000250}.
FT   MOD_RES     167    167       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     720    720       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     970    970       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BMJ2}.
FT   MOD_RES    1047   1047       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BMJ2}.
FT   VAR_SEQ       1    691       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_057204.
FT   VAR_SEQ       1     54       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_057205.
FT   VARIANT      82     82       K -> R (in dbSNP:rs112954500).
FT                                {ECO:0000269|PubMed:22607940}.
FT                                /FTId=VAR_070437.
FT   VARIANT     373    373       Y -> C (in ILFS1; dbSNP:rs201861847).
FT                                {ECO:0000269|PubMed:22607940}.
FT                                /FTId=VAR_070438.
FT   VARIANT    1088   1088       R -> K (in dbSNP:rs10988).
FT                                {ECO:0000269|Ref.1}.
FT                                /FTId=VAR_052637.
FT   CONFLICT    271    271       V -> A (in Ref. 1; BAA95667).
FT                                {ECO:0000305}.
FT   CONFLICT    892    892       N -> D (in Ref. 1; BAA95667).
FT                                {ECO:0000305}.
FT   CONFLICT   1026   1026       Y -> C (in Ref. 7; AAI31799).
FT                                {ECO:0000305}.
FT   STRAND      263    274       {ECO:0000244|PDB:2WFD}.
FT   HELIX       277    282       {ECO:0000244|PDB:2WFD}.
FT   STRAND      287    294       {ECO:0000244|PDB:2WFD}.
FT   HELIX       296    301       {ECO:0000244|PDB:2WFD}.
FT   STRAND      304    307       {ECO:0000244|PDB:2WFD}.
FT   STRAND      309    311       {ECO:0000244|PDB:2WFD}.
FT   STRAND      314    317       {ECO:0000244|PDB:2WFD}.
FT   STRAND      323    326       {ECO:0000244|PDB:2WFD}.
FT   HELIX       328    335       {ECO:0000244|PDB:2WFD}.
FT   TURN        336    338       {ECO:0000244|PDB:2WFD}.
FT   STRAND      339    342       {ECO:0000244|PDB:2WFD}.
FT   STRAND      348    351       {ECO:0000244|PDB:2WFD}.
FT   HELIX       354    357       {ECO:0000244|PDB:2WFD}.
FT   STRAND      361    363       {ECO:0000244|PDB:2WFD}.
FT   STRAND      368    370       {ECO:0000244|PDB:2WFD}.
FT   STRAND      372    376       {ECO:0000244|PDB:2WFD}.
FT   STRAND      382    385       {ECO:0000244|PDB:2WFD}.
FT   STRAND      387    391       {ECO:0000244|PDB:2WFD}.
FT   TURN        393    395       {ECO:0000244|PDB:2WFD}.
FT   HELIX       397    408       {ECO:0000244|PDB:2WFD}.
FT   HELIX       411    414       {ECO:0000244|PDB:2WFD}.
FT   TURN        415    417       {ECO:0000244|PDB:2WFD}.
FT   HELIX       420    422       {ECO:0000244|PDB:2WFD}.
FT   TURN        423    425       {ECO:0000244|PDB:2WFD}.
FT   STRAND      432    434       {ECO:0000244|PDB:2WFD}.
FT   TURN        435    437       {ECO:0000244|PDB:2WFD}.
FT   STRAND      438    440       {ECO:0000244|PDB:2WFD}.
FT   HELIX       441    448       {ECO:0000244|PDB:2WFD}.
FT   HELIX       457    474       {ECO:0000244|PDB:2WFD}.
FT   HELIX       487    500       {ECO:0000244|PDB:2WFD}.
FT   STRAND      503    508       {ECO:0000244|PDB:2WFD}.
SQ   SEQUENCE   1176 AA;  134466 MW;  44A4D1A1EF31634A CRC64;
     MAERKGTAKV DFLKKIEKEI QQKWDTERVF EVNASNLEKQ TSKGKYFVTF PYPYMNGRLH
     LGHTFSLSKC EFAVGYQRLK GKCCLFPFGL HCTGMPIKAC ADKLKREIEL YGCPPDFPDE
     EEEEEETSVK TEDIIIKDKA KGKKSKAAAK AGSSKYQWGI MKSLGLSDEE IVKFSEAEHW
     LDYFPPLAIQ DLKRMGLKVD WRRSFITTDV NPYYDSFVRW QFLTLRERNK IKFGKRYTIY
     SPKDGQPCMD HDRQTGEGVG PQEYTLLKLK VLEPYPSKLS GLKGKNIFLV AATLRPETMF
     GQTNCWVRPD MKYIGFETVN GDIFICTQKA ARNMSYQGFT KDNGVVPVVK ELMGEEILGA
     SLSAPLTSYK VIYVLPMLTI KEDKGTGVVT SVPSDSPDDI AALRDLKKKQ ALRAKYGIRD
     DMVLPFEPVP VIEIPGFGNL SAVTICDELK IQSQNDREKL AEAKEKIYLK GFYEGIMLVD
     GFKGQKVQDV KKTIQKKMID AGDALIYMEP EKQVMSRSSD ECVVALCDQW YLDYGEENWK
     KQTSQCLKNL ETFCEETRRN FEATLGWLQE HACSRTYGLG THLPWDEQWL IESLSDSTIY
     MAFYTVAHLL QGGNLHGQAE SPLGIRPQQM TKEVWDYVFF KEAPFPKTQI AKEKLDQLKQ
     EFEFWYPVDL RVSGKDLVPN HLSYYLYNHV AMWPEQSDKW PTAVRANGHL LLNSEKMSKS
     TGNFLTLTQA IDKFSADGMR LALADAGDTV EDANFVEAMA DAGILRLYTW VEWVKEMVAN
     WDSLRSGPAS TFNDRVFASE LNAGIIKTDQ NYEKMMFKEA LKTGFFEFQA AKDKYRELAV
     EGMHRELVFR FIEVQTLLLA PFCPHLCEHI WTLLGKPDSI MNASWPVAGP VNEVLIHSSQ
     YLMEVTHDLR LRLKNYMMPA KGKKTDKQPL QKPSHCTIYV AKNYPPWQHT TLSVLRKHFE
     ANNGKLPDNK VIASELGSMP ELKKYMKKVM PFVAMIKENL EKMGPRILDL QLEFDEKAVL
     MENIVYLTNS LELEHIEVKF ASEAEDKIRE DCCPGKPLNV FRIEPGVSVS LVNPQPSNGH
     FSTKIEIRQG DNCDSIIRRL MKMNRGIKDL SKVKLMRFDD PLLGPRRVPV LGKEYTEKTP
     ISEHAVFNVD LMSKKIHLTE NGIRVDIGDT IIYLVH
//
